Annual ReportHealthcare

Wockhardt Limited

WOCKPHARMA.NS · Period ending 2026-03-31 · Filed 2026-03-31 · Updated

In short

Wockhardt Limited (WOCKPHARMA.NS) has revenue up 13.8% to INR 33.2B and gross profit up 22.9% to INR 21.0B year on year. Its net margin is 6.4% and gross margin 63.4%, and it trades at 80.0× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

₹1,996.40

Market Cap

₹324.4B

P/E (TTM)

79.3x

Price ÷ earnings per share

P/B

6.7x

Price ÷ book value

P/S (TTM)

8.9x

Price ÷ revenue per share

Beta

1.00

Moderate market correlation

52-Week Range

₹1,086.70₹1,996.40 now₹2,422.30

4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)

Efficiency
42/100
Value
29/100
Cashflow
50/100
Regime
50/100

P/E 79.3× — premium valuation.

Based on filing period ending Mar 2026

International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.

WOCKPHARMA.NS vs

🇮🇳 India Macro Indicators

Full dashboard →

Policy Rate

6.75%↑

Restrictive

USD/INR

95.449→

The India central bank policy rate stands at 6.75% — a restrictive rate environment; USD/INR is at 95.449.

SWOT Analysis — WOCKPHARMA.NS

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • Operating Cash Flow: INR 3.9B (+1872.7% YoY) — Operating cash flow grew 1873% — the business generated more cash from day-to-day operations.

  • Net Income: INR 2.1B (+553.2% YoY) — Profit grew 553% — the company kept more of each dollar earned.

  • EPS (Diluted): INR 13.10 (+533.8% YoY) — Earnings per share rose 534% — each share earned more.

  • Gross Profit: INR 21.0B (+22.9% YoY) — Gross profit rose 23% — the spread between revenue and direct costs improved.

  • Revenue: INR 33.2B (+13.8% YoY) — Revenue grew 14% — the company sold more goods or services than the prior year.

◈

Weaknesses

No material weaknesses flagged.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

  • P/E ratio of 80x is very elevated — the stock price reflects aggressive growth expectations. Any earnings miss could trigger a sharp re-rating.

Financial Charts

Revenue vs Net Income

Gross Profit vs Operating Income

Margin Trend

Year-over-Year Changes

Operating Cash Flow

INR 3.9B

was -INR 220.0M

+1872.7%

Operating cash flow grew 1873% — the business generated more cash from day-to-day operations.

Net Income

INR 2.1B

was -INR 470.0M

+553.2%

Profit grew 553% — the company kept more of each dollar earned.

EPS (Diluted)

INR 13.10

was INR -3.02

+533.8%

Earnings per share rose 534% — each share earned more.

Gross Profit

INR 21.0B

was INR 17.1B

+22.9%

Gross profit rose 23% — the spread between revenue and direct costs improved.

Revenue

INR 33.2B

was INR 29.1B

+13.8%

Revenue grew 14% — the company sold more goods or services than the prior year.

Risk Flags

0 high · 1 medium · 0 low
  • ◈ Medium

    P/E ratio of 80x is very elevated — the stock price reflects aggressive growth expectations. Any earnings miss could trigger a sharp re-rating.

Price HistoryINR

Technical Signals

Daily closes · 1-year data

Latest News

via Finnhub

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Research Wockhardt Limited

Data sourced from NSE India, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.